Heparin Trial Lawyer Advertising Programxxxxxxx1-800-334-4500

Are you a personal injury attorney or law firm seeking per inquiry marketing and per inquiry advertising related to Heparin?  Last Second Media (LSM) can deliver new case inquiries for Heparin from direct response marketing.

Allergic reactions and wrongful deaths have been linked to the use of Heparin.  In fact, the Manufacture of Heparin has been Halted Due to Serious Allergic Reactions in Patients.

LSM can provide Heparin leads for your law firm on a national scale.

Heparin is a highly-sulfated glycosaminoglycan, is widely used as an injectable anticoagulant and has the highest negative charge density of any known biological molecule.[1] It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machines.

Serious reactions to Heparin have included difficulty breathing, nausea, vomiting, excessive sweating, and rapidly falling blood pressure that can lead to life-threatening shock. Four people have died after receiving heparin.

About 350 adverse events associated with the Baxter product have been reported since the end of last year compared to less than 100 reports in 2007, according to the Agency.

The LSM Heparin Trial Lawyer Advertising Program Uses Per Inquiry Radio, Per Inquiry TV, Per inquiry Newsprint and Web Video Marketing to Lock Up Wrongful Death Cases Involving Heparin

Our Heparin trial lawyer marketing program rapidly acquires tort liability cases including Heparin product liability, Heparin medical malpractice and wrongful death cases involving Heparin.  Our Heparin trial lawyer marketing program can power personal injury law practices or co-counsel lawyer advertising at a fraction of the cost using traditional direct response television advertising.

Last Second Media founder and President, Frank Pournelle has honed his process and system of using direct response media since 2001 to help attorneys secure thousands of new cases.  His experience in medical tort liability case acquisition includes Heparin, Digitek, Chantix, Asbestosis, Mesothelioma and Silicosis; Vioxx / Celebrex / Bextra; Fen Phen / PPH; Zyprexa  / Seroquel ; ACE Inhibitors; Baycol / Rhabdomyolysis; and Paxil / Zoloft.  Medical malpractice and product liability experience includes ATV rollover, contact lens solution, defibulator and hernia patch cases.

Pournelle saysOur specialized direct marketing firm has delivered thousands of new tort liability cases for legal firms in just a matter of a week. With one call we can create commercial scripts with both emotional appeal and self-selecting criteria; shoot sharp TV and web video spots; develop an excellent call center screening process; enlist hundreds of broadcasters nationally; deploy hundreds of memorable toll-free numbers for tracking; and access potential cases months ahead of the competition. We practice the Science of Law Firm Marketing to startgenerating new leads today for a client.” This per inquiry advertising program can be initiated for Digitek® (digoxin) in as little as 3 days.

Last Second Media uniquely implements a yield analysis program called Broadcast ROI, helping to provide case volume estimates.  The LSM econometrics department is also the first to develop the Depleting Inventory Model for maximizing lead volume at a lower cost while providing an early advantage on still-developing product recalls, toxic torts and product liability incidents.

Lead flow is rapid. By tapping their own radio inventory on over 230 radio stations across 26 states, clients of Last Second Media’s www.Direct-Response-Radio.com can be on air in a matter of days.  Further, Last Second Media’s per-inquiry TV programs can be initiated in less than a week in their exclusive wired network.  Lastly, the WebVideoLaunch.com program can provide top ranking on organic search terms in as little as 10 hours.   Over a 90 day period, thousands of television, cable, satellite, and radio  can be added.

In the long term, Last Second Media can outlast client competition by eliminating the risk of advertising with per inquiry media programs that allow a law firm to pay only when customers respond to advertising.  “Per Inquiry is an unfair advantage for national lawyer advertising”, says LSM Vice President of Business Development, Robert Visco. “A client can profitably obtain new cases long after competitors stop running cash media to secure tort liability cases.  Economically, LSM let’s you increase your law firm's profit margin with lower costs, greater longevity, and greater reach. We are openly experts at marketing of legal services nationally.” Mr. Visco is an MBA graduate of the Hass School of Business at the University of California at Berkeley.

Unlike a traditional internet marketing and advertising company, Last Second Media combines multiple offline media to stimulate and drive response for clients rather than serve existing demand or simply create comparison shopping for counsel on the web.

This strategic combination of Per Inquiry Radio, Per Inquiry TV, Per inquiry Newsprint and Web Video Marketing powerfully drives mass tort actions, product liability and product recall litigation. The LSM program may now be deployed to secure  Heparin cases on a pay-per-call (PPC) basis.

Last Second Media delivers massive economies over traditional advertising by creating a pseudo-partnership between broadcasters and law firms using millions of dollars in unsold advertising inventory to reach injured parties, their families and their caregivers. 

Among the products LSM has helped prosecute are:  Heparin, Digitek, Chantix, heart valves, dialysis, breast implants and IUDs; heavy machinery, engines, automobiles,  ATV’s and fire trucks; consumer electronics; tobacco and food products; chemical and industrial products and building materials, including asbestos, smoke detectors and toys;  juvenile products and furniture, home appliances; gas valves; power tools; boilers; and water coolers.

LSM is actively seeking new law firm clients to procure Heparin cases. LSM also seeks a client in categories involving clean room birth defects from chip manufacturers, DTP vaccine, anti-convulsants, antibiotics, birth control devices, lead pigment; Semi, truck and commercial trucking accidents; fertilizers and pesticides; silica filter aid products; insurance and social security coverage, environmental criminal liability, product safety and liability, Superfund and environmental cleanup liability.                                        

In short, the team of Last Second Media specialize in securing and managing pay-per-lead media campaigns for Heparin using television, radio, newspaper and web video for lawyer advertising. They are highly efficient and frugal.

In the main, a client firm pays for each valid or qualified Heparin lead after testing.  More importantly, the proven operation process of LSM will target, attract, qualify and process candidates so that law clients can concentrate on managing their business and law practice with no additional staff or learning curve. 

To date, LSM estimates helping to secure over $100 million in legal settlements for attorneys, their law firms and afflicted families.

If you and your firm would have interest in a highly effective process for securing national tort liability cases through direct marketing, contact Frank Pournelle, President, Last Second Media Inc. at 1-800-334-4500 or by visiting www.Direct-Response-Radio.com, www.LastSecondMedia.TV or www.WebVideoLaunch.com .

See whats new...Press and News Articles





PI TV Sitemap Blogs DRTV Video Links

LastSecondMedia

Founded Nov 3, 2003 to provide innovative and profitable lead generation programs that propel growth.

We use the scientific methods of Direct Response Marketing to test, modify then scale marketing programs for million dollar gains.

FREE Media & Offer Consultation + Get Our Keyword Disruption Proposal

keyworddisruption
Name
Phone
E-Mail
WJPG9L
Please Enter The Above Text (All Caps)
 

 

12,111 TV Spots Just $5K

:30 Cable Advertising That Fell Off a Truck

As Little as $1.95 CPM

What's NewView Demo